Literature DB >> 24511415

Natural orifice transluminal endoscopic surgery and upper gastrointestinal tract.

Chan Gyoo Kim1.   

Abstract

Since the first transgastric natural orifice transluminal endoscopic surgery was described, various applications and modified procedures have been investigated. Transgastric natural orifice transluminal endoscopic surgery for periotoneoscopy, cholecystectomy, and appendectomy all seem viable in humans, but additional studies are required to demonstrate their benefits and roles in clinical practice. The submucosal tunneling method enhances the safety of peritoneal access and gastric closure and minimizes the risk of intraperitoneal leakage of gastric air and juice. Submucosal tunneling involves submucosal tumor resection and peroral endoscopic myotomy. Peroral endoscopic myotomy is a safe and effective treatment option for achalasia, and the most promising natural orifice transluminal endoscopic surgery procedure. Endoscopic full-thickness resection is a rapidly developing natural orifice transluminal endoscopic surgery procedure for the upper gastrointestinal tract and can be performed with a hybrid natural orifice transluminal endoscopic surgery technique (combining a laparoscopic approach) to overcome some limitations of pure natural orifice transluminal endoscopic surgery. Studies to identify the most appropriate role of endoscopic full-thickness resection are anticipated. In this article, I review the procedures of natural orifice transluminal endoscopic surgery associated with the upper gastrointestinal tract.

Entities:  

Keywords:  Endoscopic full-thickness resection; Natural orifice transluminal endoscopic surgery; Peroral endoscopic myotomy

Year:  2013        PMID: 24511415      PMCID: PMC3915181          DOI: 10.5230/jgc.2013.13.4.199

Source DB:  PubMed          Journal:  J Gastric Cancer        ISSN: 1598-1320            Impact factor:   3.720


Introduction

Natural orifice transluminal endoscopic surgery (NOTES) is a new minimally invasive surgery that accesses the peritoneal or thoracic spaces through a transvisceral incision instead of a skin incision. To overcome the technical limitations of NOTES, a hybrid NOTES technique, which combines a transcutaneous rigid laparoscopic approach with pure NOTES, can be used. Possible transvisceral routes for hybrid NOTES include transesophageal, transgastric, transcolonic, and transvaginal routes. In theory, NOTES could reduce postoperative pain, wound complications, and the need for anesthesia, improve cosmetic results, and accelerate patient recovery and return to normal function, although these benefits have not been fully proven.1 The current upper gastrointestinal tract-related NOTES procedures have been performed in humans for transgastric organ resection (i.e., cholecystectomy, appendectomy), transgastric peritoneoscopy, transesophageal procedures (peroral endoscopic myotomy, POEM), and endoscopic full-thickness resection (EFTR). This paper reviews the NOTES procedures associated with the upper gastrointestinal tract in humans.

Transgastric Intraperitoneal Natural Orifice Transluminal Endoscopic Surgery Using Direct Incision

NOTES was first performed for transgastric peritoneoscopy in pigs.2 The peritoneal cavity was entered by direct incision of the anterior gastric wall with a needle knife, followed by dilation of the tract with a balloon dilator. After this first report, various NOTES procedures were tested in animal models, and the transgastric route was preferred in the beginning of NOTES because gastroscopy was familiar with gastroenterologist procedures.3 Current transgastric intraperitoneal NOTES procedures using direct incision have been used in humans for peritoneoscopy, cholecystectomy, and appendectomy. The first NOTES peritoneoscopy performed in humans was reported in 2008.4 Ten patients underwent diagnostic laparoscopy followed by transgastric access and endoscopic peritoneoscopy. Transgastric NOTES peritoneoscopy was reported to be safe in all patients, and the mean duration of the procedure was 24.8 minutes. The largest study of transgastric cholecystectomy in humans was reported in 2010.5 A total of 27 transgastric cholecystectomies were performed by hybrid NOTES, and the rate of complications such as gastric hematoma, abdominal sepsis, and esophageal perforations was 18%. A recent study including 14 consecutive transgastric appendectomies6 showed that two patients with purulent peritonitis required laparoscopic lavage several days after the procedure, although no leaks were detected at the appendiceal stump or stomach. All of these transgastric intraperitoneal NOTES procedures were successful in humans, but are not widely applied in clinic practice. In a recent randomized study in a porcine model, transgastric peritoneoscopy showed worse outcomes than laparoscopic peritoneoscopy. Standard laparoscopy provided significantly better lesion detection (78.5% vs. 38.9%), organ visualization (7.15 vs. 4.35), and biopsy capability (87% vs. 65%) than transgastric NOTES.7 Additional studies on transgastric cholecystectomy and appendectomy are required to demonstrate their role in clinical practice.

Submucosal Tunneling Method

Submucosal tunneling was developed to guarantee safe peritoneal access, secure gastric closure, and accelerate healing of the incision site. The submucosal tunnel was created using endoscopic submucosal dissection techniques and tools. After submucosal injection of 5 to 15 ml of normal saline, a 2-cm incision was made in the mucosa using ESD knives. Submucosal dissection was then performed to create a submucosal tunnel. The length of the tunnel depended on the type of procedure. A 4 to 5 cm tunnel was adequate for subepithelial tumor dissection, but a 10-cm tunnel was used for POEM. After the NOTES procedure, closure of the mucosal incision was performed using several endoscopic clips.8,9 Submucosal tunneling has the advantage8,9 of the seromuscular incision site being situated far from the mucosal incision site, which allows minimization of any intraperitoneal leakage of gastric content and air by the narrow, long submucosal tract during the procedure. Maintaining gastric distension even after seromuscular incision allows better endoscopic view and working space, thus allowing easy placement of the clips for closure of the incision. Approximated surfaces of the narrow and longitudinal tunnel healed rapidly. Submucosal tunneling can be used for transgastric intraperitoneal procedures, dissection of subepithelial tumors, and POEM. The initial submucosal tunneling procedure was access peritoneum via stomach.8 Diagnostic transgastric peritoneoscopy using submucosal tunneling was successful with the patient under conscious sedation.10 However, in a recent randomized trial in an animal model, submucosal tunneling was found to permit lower visualization than direct incision.11 Laparoscopic resection is not easy for subepithelial tumors that are located in the esophagus or gastric cardia. For these locations, dissection of subepithelial tumors using the submucosal tunneling technique is a possible alternative intervention. Several recent retrospective studies have shown a 78% to 100% rate of successful subepithelial tumor resection using submucosal tunneling (Table 1).12-17 Frequent complications seen were pneumothorax and subcutaneous emphysema, which improved in most cases with conservative management, although a few patients required chest tube insertion or subcutaneous puncture.16,17 Further studies are required to demonstrate the efficiency of this technique for subepithelial tumors (particularly gastrointestinal stromal tumors) with regard to its safety and ability to achieve complete resection with an intact capsule. The long-term follow-up data after resection is also required.
Table 1

Published studies on submucosal tunneling method for subepithelial tumors

GIST = gastrointestinal stromal tumor. *Success of complete and en bloc resection by submucosal tunneling method. †Unknown location of one case. ‡Failed for large subepithelial tumors (60 mm and 75 mm).

Peroral Esophageal Myotomy

Achalasia is the primary esophageal motility dysfunction disorder. The loss of inhibitory neurons of the myenteric plexus results in failure of the lower esophageal sphincter to relax in response to swallowing. Traditional treatments include pharmacological management, endoscopic intervention (botulinum toxin injection, pneumatic dilation), and surgical treatment (laparoscopic Heller myotomy, LHM). LHM has shown the most satisfactory long-term results. The overall success rate of LHM was 77.0% to 97.2%.18 POEM is a new endoscopic treatment modality for achalasia. Endoscopic myotomy was first used in achalasia patients 30 years ago with the needle knife used for direct incision of muscle at the esophagogastric junction (EGJ).19 Pasricha et al.20 first described the current method using submucosal tunneling and an insulated-tip knife in a pig model, which was then performed by Inoue et al.21 in humans. POEM consists of several steps. 1) After submucosal injection, a 2-cm long mucosal incision is made at approximately 10 to 13 cm proximal to the EGJ. 2) A long submucosal tunnel is created 2 to 3 cm distal to the EGJ. 3) Endoscopic myotomy is performed 3 to 5 cm distal from the mucosal incision site in a proximal to distal direction. Long endoscopic myotomy of the inner circular muscle bundles is performed using an insulated-tip knife, leaving the outer longitudinal muscle layer intact. The expected end point of myotomy is 2 cm distal to the EGJ. 4) The mucosal incision is closed using hemostatic clips. The learning curve for POEM plateaus at approximately 20 cases for experienced endoscopists.22 Over 10 reports of POEM use for achalasia have been published, and these indicate good short-term results without serious complications. In a recent international prospective multicenter study on POEM of 70 patients at five centers in the Europe and North America, the endoscopist had to perform at least two procedures under the direct guidance of an endoscopist with good experience in performing POEM, prior to performing POEM independently.23 All procedures were successful, and no conversions to laparoscopic or open surgery were required. The percentage of patients in symptom remission at 3, 6, and 12 months was 97%, 89%, and 82%, respectively. POEM has several theoretical advantages over LHM because it is less invasive and can allow myotomy to be performed in the proximal esophagus. Extending the distance to allow LHM to be performed in the thoracic esophagus is difficult in patients with advanced disease, and the risk of injury to the vagus nerve is lower with POEM because myotomy is performed from inside the esophageal lumen. Because the target area for POEM is the lateral side of the esophagus and that for LHM is the anterior side, a subsequent LHM is a feasible second-line treatment if POEM fails.23 Acid reflux is a major complication after successful LHM and POEM. Addition of an anti-reflux procedure to LHM can substantially reduce the incidence and severity of acid reflux.24,25 The incidence of reflux after LHM, with or without an anti-reflux procedure is 3% to 34% according to the literature.18 In a multicenter study, the rate of acidic reflux was 42% at 3 months after POEM.23 Although the rate of reflux after POEM appears to be higher than that after LHM, the severity of esophagitis was minor (grade A or B) and only 12% of patients required daily proton pump inhibitor therapy.23 Currently, no randomized trial has compared LHM with POEM. Outcomes of POEM were comparable with those of LHM in short-term retrospective studies and long-term prospective randomized trials are required.26-28

Endoscopic Full-Thickness Resection

Conventional endoscopic submucosal dissection techniques are not used for subepithelial tumors originating from, or infiltrating into, the muscularis propria layer because of the increased risk of incomplete resection and perforation. Laparoscopic wedge resection is a minimally invasive treatment that is effective for most subepithelial tumors, and is usually performed from outside the stomach using a linear stapler. The exogastric approach with a linear stapler can lead to excessive resection of healthy tissue of the gastric wall resulting in deformity or stenosis. Attaining a positive surgical margin is also possible. EFTR can be used for tumor resection by direct visualization of the tumor from inside the stomach lumen leading to a free surgical margin with little resection of healthy tissue. EFTR can be performed using pure NOTES that involves only endoscopy without laparoscopy (Table 2).29-31 In a simple method of EFTR, gastric tumors can be grasped and lifted by the tissue anchor and then resected with a snare.29 In other procedures, the tumors are separated from the muscularis layer using an insulated-tip knife under direct vision until less than one-fifth of the lesion remains, and then a snare used.30 In the most detailed procedure, a circumferential incision is made as deep as the muscularis propria around the lesion, and incision of the serosal layer is performed with a Hook knife or insulated-tip knife. Finally, the tumor is removed with a snare.31 En bloc resection rates were 100% and no patient had severe complications, although 2 of the 20 patients needed ultrasound-guided percutaneous puncture for drainage of the abdominal cavity effusion in a retrospective study.30
Table 2

Published studies on endoscopic full-thickness resection with pure NOTES in humans

NOTES = natural orifice transluminal endoscopic surgery; GIST = gastrointestinal stromal tumor; OTSC = over-the-scope clip. *Success of complete and en bloc resection followed by clipping using pure NOTES. †In 6 of 20 cases, pure NOTES was impossible and conversion to laparoscopic wedge resection was necessary due to extraluminal growth and the large size of the tumors. Incomplete resection with positive deep margins occurred in 2 cases of 14 patients in the pure NOTES group. ‡Needed ulltrosound-guided percutaneous puncture drainage.

The most important step of EFTR with pure NOTES is the successful closure of the gastric wall opening after resection. Multiple metallic clips and endoloop and over-the-scope clips have been used for successful closure.29-31 These studies showed the possibility of performing endoscopic resection without the need for laparoscopy. However, appropriate indication (i.e., location and size of the subepithelial tumor), details of procedures (i.e., resection and closure methods), and other management requirements for patients (i.e., pre- and post-management) should be studied before widely using pure NOTES for subepithelial tumors. Hybrid NOTES (combining NOTES with laparoscopic approach) is more acceptable than pure NOTES. Hybrid NOTES has been applied for gastric subepithelial tumors and early gastric cancer (EGC). Hiki et al.32 developed a hybrid NOTES procedure called laparoscopic and endoscopic cooperative surgery.33 The gastric wall was perforated using a needle knife from inside the stomach lumen after circumferential submucosal dissection. Seromuscular dissection and closure of the opening were performed using a laparoscopic procedure at the peritoneum. Two recent studies showed that laparoscopic and endoscopic cooperative surgeries for gastric subepithelial tumors (n=7 and n=20) were successful without complications.32,33 Endoscopic seromuscular incision (EFTR) was performed by Abe et al.34,35 After circumferential submucosal dissection, endoscopic full-thickness (from the muscle layer to the serosal layer) cut around three-fourths of the circumference of the above-mentioned submucosal incision was made under laparoscopic supervision. Complete resection and closure of the wall defect were performed by the laparoscopic approach from the peritoneal cavity. Abe et al.35 presented four cases of sub-endothelial tumors that were successfully resected using EFTR with laparoscopic assistance with no complications and minimal resection of healthy tissue. The mean size of the resected specimens and tumors was 37 mm and 30 mm, respectively. In this study, the advantage of EFTR over conventional laparoscopic wedge resection was the minimal resection of healthy tissue. Theoretically, EFTR with laparoscopic assistance can be used for lesions located near the EGJ or the pyloric ring because conventional laparoscopic wedge resection for these lesions is technically complex. Further investigations to evaluate the advantages of EFTR are needed. EFTR can also be used to treat EGCs. Abe et al.34 first reported EFTR with laparoscopic assistance for EGC, followed by a prospective pilot study by Cho et al.36 Lymph node dissection including sentinel lymph node navigation was performed before EFTR. EFTR needed to be converted to subtotal gastrectomy in 5 of 14 EGCs because of issues with reconstruction, insufficient vascular flow after gastric wall closure, and leakage at the suture site. Although this study showed that EFTR was technically successful, two important barriers hinder its wide application for EGCs. First, the safety and effectiveness of sentinel lymph node biopsy should be confirmed. A recent multicenter, single-arm phase II study showed promising outcomes for sentinel lymph node biopsy in gastric cancer.37 Confirmation using randomized phase III studies is needed. Another barrier is the current EFTR technique because the gastric mucosa is exposed to the peritoneum, which could cause flow of gastric juice into the peritoneal cavity. The mucosal cancer is exposed and manipulated in the peritoneum from the open gastric wall incision. Therefore, it is difficult to completely prevent viable cancer cell seeding into the peritoneal cavity. Developing a nonexposure technique is a possible solution. Recently, two nonexposure techniques have been developed. After laparoscopic circumferential seromuscular dissection from the peritoneal cavity, the tumor was resected endoscopically or using a stapler. The opening was sutured using a linear stapler or was hand-sewn.38,39 However, laparoscopic seromuscular hand-sewn suture and laparoscopic circumferential seromuscular dissection without perforation may not be easy. Intraoperative perforations occurred in 2 of 6 cases, and the mean operation time was 349 minutes in the first 3 cases and 198 minutes in the remaining 3 cases.39 Easier, safer, and more effective techniques may be needed.

Risks of Infection

Contamination of the peritoneal cavity is a big concern during NOTES procedures because an endoscope is passed through the unsterile upper gastrointestinal tract into the usually sterile peritoneal cavity. NOTES peritoneoscopy and intraperitoneal procedures (i.e., biopsy or organ extraction) need intraperitoneal navigation of the endoscope, and sterile methods may be needed for these procedures. In a randomized controlled study in a live porcine model, all non-sterile pigs (n=8) showed gross infection in the peritoneal cavity, including fibrinopurulent exudates, pus, and abscesses.40 The pigs in the non-sterile group underwent the procedure with non-sterile endoscopes and accessories, no antiseptic lavage of the gastric and oral cavities, and no antibiotics. On the other hand, all pigs in the sterile group demonstrated no gross evidence of intraperitoneal infection and negative cultures when samples were obtained from the peritoneal cavity.40 In another randomized study in a porcine model, the use of intravenous antibiotics with topical antimicrobial lavage of the mouth and stomach decreased the peritoneal bacterial load to almost zero, and this was associated with a significantly lower peritoneal infection rate than that with saline lavage.41 However, the extent of sterile methods needed is unclear. Aggressive maximal sterile techniques include disinfection of the stomach and oral cavity, and use of intravenous antibiotics, sterile endoscopes with sterile overtubes, and sterile gowns, gloves, and face masks.40 In a randomized study in pigs, excluding disinfection of the stomach and oral cavity, these techniques were not associated with postoperative clinically relevant infections, although bacterial contamination could occur.42 Moreover, excluding the sterilization of the oroesophageal overtube and decontamination of the stomach, these techniques were not associated with infectious complications in human trials, although these studies had a small number of participants (n=8 or n=10).43,44 Whether proton pump inhibitors (PPIs), which raise the gastric pH resulting in increased bacterial colonization of the stomach, increase the risk of peritoneal infection was not determined. In a rat model, pretreatment with a PPI resulted in a higher rate of peritoneal bacterial contamination (PPI vs. control; 60% vs. 20%) and abscess formation (33% vs. 13%).45 On the other hand, leakage of gastric juice into the peritoneum leads to chemical peritonitis. In a pig model, an aggressive sterile technique using PPI demonstrated no gross or bacteriological evidence of infection.40 The infection risk with POEM and EFTR seems to be lower than that with NOTES peritoneoscopy because the endoscope does not navigate the sterile peritoneum or mediastinum in POEM and EFTR. No penetration of endoscope occurs during procedure, with only the insulated-tip knife penetrating the gastric and esophageal walls. In addition, the insulated tip knife does not make contact with the peritoneal or mediastinal organs. In fact, the clinical outcomes of recent POEM and EFTR studies have shown no significant infection, although antibiotics may be needed in the pre- or post-procedures.12-17,29-31 Therefore, I assume that infection is not an obstacle to the use of NOTES in the upper gastrointestinal tract if appropriate disinfection is performed for each procedure.

Conclusions

Various transgastric NOTES procedures such as periotoneoscopy, cholecystectomy, and appendectomy have been investigated in humans. However, transgastric NOTES procedures have not been used widely because of its obscure benefits and roles. On the other hand, POEM has several advantages, and recent studies on POEM show good outcomes without serious complications. EFTR is a developing technology, and previous data on its use with pure or hybrid NOTES techniques indicate that it may be a feasible treatment method for subepithelial tumors. Favorable outcomes for EFTR are anticipated in the future.
  45 in total

1.  Peroral endoscopic myotomy (POEM) for esophageal achalasia.

Authors:  H Inoue; H Minami; Y Kobayashi; Y Sato; M Kaga; M Suzuki; H Satodate; N Odaka; H Itoh; S Kudo
Journal:  Endoscopy       Date:  2010-03-30       Impact factor: 10.093

2.  Transgastric appendicectomy.

Authors:  G Kaehler; M B Schoenberg; P Kienle; S Post; R Magdeburg
Journal:  Br J Surg       Date:  2013-04-11       Impact factor: 6.939

3.  Peroral endoscopic myotomy for the treatment of achalasia: an international prospective multicenter study.

Authors:  Daniel Von Renteln; Karl-Hermann Fuchs; Paul Fockens; Peter Bauerfeind; Melina C Vassiliou; Yuki B Werner; Gerald Fried; Wolfram Breithaupt; Henriette Heinrich; Albert J Bredenoord; Jan F Kersten; Tessa Verlaan; Michael Trevisonno; Thomas Rösch
Journal:  Gastroenterology       Date:  2013-05-09       Impact factor: 22.682

4.  Sentinel node mapping for gastric cancer: a prospective multicenter trial in Japan.

Authors:  Yuko Kitagawa; Hiroya Takeuchi; Yu Takagi; Shoji Natsugoe; Masanori Terashima; Nozomu Murakami; Takashi Fujimura; Hironori Tsujimoto; Hideki Hayashi; Nobunari Yoshimizu; Akinori Takagane; Yasuhiko Mohri; Kazuhito Nabeshima; Yoshikazu Uenosono; Shinichi Kinami; Junichi Sakamoto; Satoshi Morita; Takashi Aikou; Koichi Miwa; Masaki Kitajima
Journal:  J Clin Oncol       Date:  2013-09-09       Impact factor: 44.544

Review 5.  Natural orifice translumenal endoscopic surgery: progress in humans since white paper.

Authors:  Byron F Santos; Eric S Hungness
Journal:  World J Gastroenterol       Date:  2011-04-07       Impact factor: 5.742

6.  Endoscopic mucosal resection, endoscopic submucosal dissection, and beyond: full-layer resection for gastric cancer with nonexposure technique (CLEAN-NET).

Authors:  Haruhiro Inoue; Haruo Ikeda; Toshihisa Hosoya; Akira Yoshida; Manabu Onimaru; Michitaka Suzuki; Shin-ei Kudo
Journal:  Surg Oncol Clin N Am       Date:  2012-01       Impact factor: 3.495

7.  Submucosal endoscopic tumor resection for subepithelial tumors in the esophagus and cardia.

Authors:  H Inoue; H Ikeda; T Hosoya; M Onimaru; A Yoshida; N Eleftheriadis; R Maselli; S Kudo
Journal:  Endoscopy       Date:  2012-02-21       Impact factor: 10.093

8.  Natural-orifice transgastric endoscopic peritoneoscopy in humans: Initial clinical trial.

Authors:  Jeffrey W Hazey; Vimal K Narula; David B Renton; Kevin M Reavis; Christopher M Paul; Kristen E Hinshaw; Peter Muscarella; E Christopher Ellison; W Scott Melvin
Journal:  Surg Endosc       Date:  2007-08-14       Impact factor: 4.584

9.  Tunneling endoscopic muscularis dissection for subepithelial tumors originating from the muscularis propria of the esophagus and gastric cardia.

Authors:  Bing-Rong Liu; Ji-Tao Song; Ling-Jian Kong; Feng-Hua Pei; Xin-Hong Wang; Ya-Ju Du
Journal:  Surg Endosc       Date:  2013-06-14       Impact factor: 4.584

10.  Submucosal tunneling using endoscopic submucosal dissection for peritoneal access and closure in natural orifice transluminal endoscopic surgery: a porcine survival study.

Authors:  F Yoshizumi; K Yasuda; K Kawaguchi; K Suzuki; N Shiraishi; S Kitano
Journal:  Endoscopy       Date:  2009-08-10       Impact factor: 10.093

View more
  3 in total

1.  Non-exposure simple suturing endoscopic full-thickness resection (NESS-EFTR) versus laparoscopic wedge resection: a randomized controlled trial in a porcine model.

Authors:  Hong Man Yoon; Chan Gyoo Kim; Jong Yeul Lee; Soo-Jeong Cho; Myeong-Cherl Kook; Bang Wool Eom; Keun Won Ryu; Young-Woo Kim; Il Ju Choi
Journal:  Surg Endosc       Date:  2017-11-03       Impact factor: 4.584

2.  Effect of peroral esophageal myotomy for achalasia treatment: A Chinese study.

Authors:  Bin Lu; Meng Li; Yue Hu; Yi Xu; Shuo Zhang; Li-Jun Cai
Journal:  World J Gastroenterol       Date:  2015-05-14       Impact factor: 5.742

Review 3.  Endoscopic Full-Thickness Resection Combined with Laparoscopic Surgery.

Authors:  Chan Gyoo Kim
Journal:  Clin Endosc       Date:  2018-01-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.